Evidence map›Paper›PMID 41847380›Full record

ReviewIJID regions2026

Challenges for the implementation of an outpatient parenteral antimicrobial therapy clinic system in Mexico.

Laura Nuzzolo-Shihadeh, Adrián Camacho-Ortiz

Abstract readReview
In one paragraph

Review in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura Nuzzolo-ShihadehCentro de Infusión de Antimicrobianos y Tratamiento de Enfermedades infecciosas (CIATI), Department of Infectious Diseases, University Hospital Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.
Adrián Camacho-OrtizCentro de Infusión de Antimicrobianos y Tratamiento de Enfermedades infecciosas (CIATI), Department of Infectious Diseases, University Hospital Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) programs were developed to deliver intravenous antibiotics to patients who no longer require hospitalization. Since their introduction in the 1970s, OPAT services have expanded worldwide, providing benefits, such as reduced hospital stay, lower costs, and improved patient satisfaction. In Mexico, OPAT programs remain scarce, with only two known clinics nationwide. Most parenteral treatments occur in informal settings without standardized protocols or trained staff. Our institutional experience demonstrates that OPAT is feasible and well accepted, even among patients with limited financial and social resources. However, implementation across Latin America faces barriers, including infrastructure, funding, and workforce limitations. Advocacy for supportive policies and evidence of cost-effectiveness are critical to achieving long-term program sustainability. Caregiver education is essential and ensures appropriate communication of questions, concerns, and potential adverse events. Finally, every patient receiving OPAT must have access to clinical services, laboratory monitoring, and follow-up with a physician. Implementation of this type of strategies could enhance sustainability and access. This perspective discusses the challenges and potential solutions to establishing OPAT services in Mexico and countries with similar healthcare models.

Indexed as

Antimicrobial stewardshipHealth systemsInfectious diseasesLatin AmericaMexicoOutpatient parenteral antimicrobial therapy (OPAT)

Identifiers

PMID41847380
PMCPMC12991834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.